Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER studyLuca Arecco, Lucia Del Mastro, Maria Maddalena Latocca et al.|The Breast|2024Cited by 3
Adjuvant Endocrine Therapy Choices in Premenopausal Patients with Hormone Receptor-Positive Early Breast Cancer: Results from the Prospective Gim23-Poster StudyLuca Arecco, Lucia Del Mastro, Maria Maddalena Latocca et al.|SSRN Electronic Journal|2024Cited by 0
A Mixed Probiotic/Prebiotic Intervention (MBR-01) for the Management of Diarrhea During Abemaciclib Treatment of Early Breast Cancer: A Single-Center Prospective Case–Control Pilot StudyD. Generali, Francesco Schettini, Alexandro Membrino et al.|medRxiv|2026Cited by 0
A mixed prebiotic/probiotic intervention (MBR-01) for the management of diarrhea during abemaciclib treatment of early breast cancer in postmenopausal patients: A single-center prospective case–control pilot studyDaniele Generali, Francesco Schettini, Alexandro Membrino et al.|The Breast|2026Cited by 0
<i>DPYD</i> -Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: A Real-World Retrospective StudyFrancesco Schettini, Daniele Generali, Marta Gatti et al.|JCO Precision Oncology|2026Cited by 0